Nanoparticle-Mediated Drug Delivery System for Cardiovascular Disease
Open accessAbstract
Administration of drugs and other therapeutic agents has been the central strategy of contemporary medicine for cardiovascular disease. The use of a drug delivery system (DDS) is always demanded to enhance the efficacy and safety of therapeutic agents, and improve the signal-to-noise ratio of imaging agents. Nano-scale materials modify in vivo drug kinetics, depending on (patho)physiological mechanisms such as vascular permeability and incorporation by the mononuclear phagocyte system, which constitute 'passive-targeting' properties of nano-DDS. By contrast, an 'active-targeting' strategy employs a specific targeting structure on nano-DDS, which binds to the target molecule that is specific for a certain disease process, such as tumor specific antigens and the induction of adhesion molecules. In this review, we summarize recent studies that applied nano-DDS for the diagnosis and treatment of cardiovascular disease, especially focusing on atherosclerosis and myocardial ischemia-reperfusion (IR) injury. Pathophysiological changes in atherosclerosis and myocardial IR injury are successfully targeted by nano-DDS and preclinical studies in animals showed positive effects of nano-DDS enhancing efficacy and reducing adverse effects. The development of nano-DDS in clinical medicine is keenly being awaited.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Indocyanine green-loaded PLGA nanoparticles accumulated exclusively in ischemic myocardium in mouse model.
“In a myocardium IR mouse model, administered indocyanine green-loaded PLGA nanoparticles accumulated exclusively in the ischemic myocardium.161”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [161]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282 · see citing works
Heart Disease and Stroke Statistics—2014 Update
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2013) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,207 · see citing works
Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A., & Schwartz, S. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1262 · Cited by 4,084 · see citing works
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Breton, A. L., & Véronique Préat, A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,884 · see citing works
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797 · see citing works
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
Hausenloy, D. J., & Yellon, D. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62874 · Cited by 2,357 · see citing works
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300 · see citing works
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107 · see citing works
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029 · see citing works
PPARγ signaling and metabolism: the good, the bad and the future
Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., & Evans, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3159 · Cited by 2,016 · see citing works
Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., & Tsujimoto, Y. (2005) · Nature · doi:10.1038/nature03317 · Cited by 1,635 · see citing works
Block copolymer micelles: preparation, characterization and application in drug delivery
Gaucher, G., Dufresne, M.-H., Sant, V. P., Kang, N., Maysinger, D., & Leroux, J.-C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.034 · Cited by 1,498 · see citing works
Targeted drug delivery via the folate receptor
Sudimack, J. J., & Lee, R. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00062-9 · Cited by 1,477 · see citing works
Motoyama, S., Sarai, M., Harigaya, H., Anno, H., Inoue, K., Hara, T., Naruse, H., Ishii, J., Hishida, H., Wong, N. D., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.068 · Cited by 1,428 · see citing works
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
Piot, C. A., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., Belghiti, R. E., Cung, T. T., Bonnefoy‐Cudraz, E., Angoulvant, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071142 · Cited by 1,339 · see citing works
Concept of Vulnerable/Unstable Plaque
Finn, A. V., Nakano, M., Narula, J., Kolodgie, F. D., & Virmani, R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179739 · Cited by 1,193 · see citing works
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,116 · see citing works
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice
Daley, J. M., Thomay, A. A., Connolly, M. D., Reichner, J. S., & Albina, J. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407247 · Cited by 1,047 · see citing works
Introduction to metallic nanoparticles
Mody, V. V., Siwale, R. C., Singh, A. V., & Mody, H. (2010) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.72127 · Cited by 1,045 · see citing works
A Tale of Coronary Artery Disease and Myocardial Infarction
Nabel, E. G., & Braunwald, E. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1112570 · Cited by 994 · see citing works
Therapeutic siRNA silencing in inflammatory monocytes in mice
Leuschner, F., Dutta, P., Gorbatov, R., Novobrantseva, T. I., Donahoe, J. S., Courties, G., Lee, K. M., Kim, J. I., Markmann, J. F., Marinelli, B., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1989 · Cited by 839 · see citing works
Imaging macrophages with nanoparticles
Weissleder, R., Nahrendorf, M., & Pittet, M. J. (2014) · Nature Materials · doi:10.1038/nmat3780 · Cited by 809 · see citing works
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Markman, J. L., Rekechenetskiy, A., Holler, E., & Ljubimova, J. Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.019 · Cited by 733 · see citing works
Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles
Matsumura, Y., & Kataoka, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01103.x · Cited by 500 · see citing works
Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography
Hyafil, F., Cornily, J.-C., Feig, J. E., Gordon, R., Vucic, E., Amirbekian, V., Fisher, E. A., Fuster, V., Feldman, L. J., & Fayad, Z. A. (2007) · Nature Medicine · doi:10.1038/nm1571 · Cited by 467 · see citing works
Long-circulating (sterically stabilized) liposomes for targeted drug delivery
Allen, T. M. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90314-x · Cited by 447 · see citing works
Ly6 family proteins in neutrophil biology
Lee, P. Y., Wang, J., Parisini, E., Dascher, C. C., & Nigrovic, P. A. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0113014 · Cited by 304 · see citing works
Mulder, W. J. M., Strijkers, G. J., van Tilborg, G. A. F., Cormode, D. P., Fayad, Z. A., & Nicolay, K. (2009) · Accounts of Chemical Research · doi:10.1021/ar800223c · Cited by 267 · see citing works
Kawashimà, Y., Yamamoto, H., Takeuchi, H., Hino, T., & Niwa, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00121-5 · Cited by 181 · see citing works
Katsuki, S., Matoba, T., Nakashiro, S., Sato, K., Koga, J.-I., Nakano, K., Nakano, Y., Egusa, S., Sunagawa, K., & Egashira, K. (2014) · Circulation · doi:10.1161/circulationaha.113.002870 · Cited by 179 · see citing works
Self-citationMorishige, K., Kacher, D. F., Libby, P., Josephson, L., Ganz, P., Weissleder, R., & Aikawa, M. (2010) · Circulation · doi:10.1161/circulationaha.109.891804 · Cited by 168 · see citing works
Dauber, I. M., VanBenthuysen, K. M., McMurtry, I. F., Wheeler, G. S., Lesnefsky, E. J., Horwitz, L. D., & Weil, J. V. (1990) · Circulation Research · doi:10.1161/01.res.66.4.986 · Cited by 149 · see citing works
How do carbon nanotubes serve as carriers for gemcitabine transport in a drug delivery system?
Arsawang, U., Saengsawang, O., Rungrotmongkol, T., Sornmee, P., Wittayanarakul, K., Remsungnen, T., & Hannongbua, S. V. (2010) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2010.11.002 · Cited by 143 · see citing works
Kimura, S., Egashira, K., Chen, L., Nakano, K., Iwata, E., Miyagawa, M., Tsujimoto, H., Hara, K., Morishita, R., Sueishi, K., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.121418 · Cited by 140 · see citing works
Self-citationFormulation of Nanoparticle-Eluting Stents by a Cationic Electrodeposition Coating Technology
Nakano, K., Egashira, K., Masuda, S., Funakoshi, K., Zhao, G., Kimura, S., Matoba, T., Sueishi, K., Endo, Y., Kawashimà, Y., et al. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.08.023 · Cited by 139 · see citing works
Self-citationTakahama, H., Minamino, T., Asanuma, H., Fujita, M., Asai, T., Wakeno, M., Sasaki, H., Kikuchi, H., Hashimoto, K., Oku, N., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.014 · Cited by 129 · see citing works
The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on
Baxter, G. F. (2002) · Basic Research in Cardiology · doi:10.1007/s00395-002-0366-7 · Cited by 126 · see citing works
Leuschner, F., & Nahrendorf, M. (2011) · Circulation Research · doi:10.1161/circresaha.110.232678 · Cited by 110 · see citing works
Howard, M. D., Greineder, C. F., Hood, E. D., & Muzykantov, V. R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.035 · Cited by 100 · see citing works
Chen, L., Nakano, K., Kimura, S., Matoba, T., Iwata, E., Miyagawa, M., Tsujimoto, H., Nagaoka, K., Kishimoto, J., Sunagawa, K., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.157032 · Cited by 89 · see citing works
Self-citationOptimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept
Bitounis, D., Fanciullino, R., Iliadis, A., & Ciccolini, J. (2012) · ISRN Pharmaceutics · doi:10.5402/2012/738432 · Cited by 80 · see citing works
Michalska, M., Machtoub, L. H., Manthey, H. D., Bauer, E., Herold, V., Krohne, G., Lykowsky, G., Hildenbrand, M. F., Kampf, T., Jakob, P. M., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.255224 · Cited by 78 · see citing works
Tsukie, N., Nakano, K., Matoba, T., Masuda, S., Iwata, E., Miyagawa, M., Zhao, G., Meng, W., Kishimoto, J., Sunagawa, K., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13862 · Cited by 71 · see citing works
Self-citationCells Involved in the Capture of Nanoparticles in Hematopoietic Organs
Gibaud, S., Demoy, M., Andreux, J. P., Weingarten, C., Gouritin, B., & Couvreur, P. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960032d · Cited by 69 · see citing works
Dendritic supramolecular assemblies for drug delivery
Morgan, M. T., Carnahan, M. A., Finkelstein, S., Prata, C. A. H., Degoricija, L., Lee, S. J., & Grinstaff, M. W. (2005) · Chemical Communications · doi:10.1039/b502411k · Cited by 69 · see citing works
Kubo, M., Egashira, K., Inoue, T., Koga, J., Oda, S., Chen, L., Nakano, K., Matoba, T., Kawashimà, Y., Hara, K., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.182584 · Cited by 63 · see citing works
Self-citationMasuda, S., Nakano, K., Funakoshi, K., Zhao, G., Meng, W., Kimura, S., Matoba, T., Miyagawa, M., Iwata, E., Sunagawa, K., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.8730 · Cited by 59 · see citing works
Self-citationKimura, S., Egashira, K., Nakano, K., Iwata, E., Miyagawa, M., Tsujimoto, H., Hara, K., Kawashimà, Y., Tominaga, R., & Sunagawa, K. (2008) · Circulation · doi:10.1161/circulationaha.107.740613 · Cited by 51 · see citing works
Self-citationNagahama, R., Matoba, T., Nakano, K., Kim‐Mitsuyama, S., Sunagawa, K., & Egashira, K. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.253823 · Cited by 48 · see citing works
Self-citationOda, S., Nagahama, R., Nakano, K., Matoba, T., Kubo, M., Sunagawa, K., Tominaga, R., & Egashira, K. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2010.03.020 · Cited by 44 · see citing works
Self-citationNanoparticle-Mediated Delivery of Anticancer Agents to Tumor Angiogenic Vessels
Asai, T. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b212013 · Cited by 36 · see citing works
Nanomedicine Captures Cardiovascular Disease
Mulder, W. J. M., & Fayad, Z. A. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.165332 · Cited by 33 · see citing works
Anti-inflammatory gene therapy for cardiovascular disease
Matoba, T., & Egashira, K. (2011) · Current Gene Therapy · doi:10.2174/156652311798192888 · Cited by 31 · see citing works
Self-citationDiagnosis and Management of STEMI Arising From Plaque Erosion
Holmes, D. R., Lerman, A., Moreno, P., King, S. B., & Sharma, S. K. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2013.01.005 · Cited by 20 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Markman JL, Rekechenetskiy A, Holler E, Ljubimova JY. Nano- medicine therapeutic approaches to overcome cancer drug resist- ance. Adv Drug Deliv Rev 2013; 65: 1866-79.
Cited by
Sorted by citations
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works
Recent applications of PLGA based nanostructures in drug delivery
Mir, M., Ahmed, N., & Rehman, A. U. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.07.038 · Cited by 626 · see citing works
Zhao, T., Wu, W., Sui, L., Huang, Q., Nan, Y., Liu, J., & Ai, K. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.06.006 · Cited by 270 · see citing works
Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases
Deng, Y., Zhang, X., Shen, H., He, Q., Wu, Z., Liao, W., & Yuan, M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00489 · Cited by 263 · see citing works
Release mechanisms and applications of drug delivery systems for extended-release
Wang, S., Liu, R., Fu, Y., & Kao, W. J. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1788541 · Cited by 163 · see citing works
Targeted delivery of therapeutic agents to the heart
Sahoo, S., Kariya, T., & Ishikawa, K. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00499-9 · Cited by 161 · see citing works
Krüppel-like factors and vascular wall homeostasis
Fan, Y., Lu, H., Liang, W., Hu, W., Zhang, J., & Chen, Y. E. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx037 · Cited by 120 · see citing works
Cell‐Based Drug Delivery and Use of Nano‐and Microcarriers for Cell Functionalization
Timin, A. S., Litvak, M. M., Gorin, D. A., Atochina‐Vasserman, E. N., Atochin, D. N., & Sukhorukov, G. B. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700818 · Cited by 112 · see citing works
Wang, K., Gao, H., Zhang, Y., Yan, H., Si, J., Mi, X., Xia, S., Feng, X., Liu, D., Kong, D., et al. (2021) · Advanced Materials · doi:10.1002/adma.202106994 · Cited by 110 · see citing works
Bioinspired Negatively Charged Calcium Phosphate Nanocarriers for Cardiac Delivery of MicroRNAs
Mauro, V. D., Iafisco, M., Salvarani, N., Vacchiano, M., Carullo, P., Ramírez‐Rodríguez, G. B., Patrício, T., Tampieri, A., Miragoli, M., & Catalucci, D. (2016) · Nanomedicine · doi:10.2217/nnm.16.26 · Cited by 105 · see citing works
Li, Y., Ye, Z., Yang, H., & Xu, Q. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.04.013 · Cited by 99 · see citing works
Ostrowski, A., Nordmeyer, D., Boreham, A., Holzhausen, C., Mundhenk, L., Graf, C. M., Meinke, M. C., Vogt, A., Hadam, S., Lademann, J. M., et al. (2015) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.6.25 · Cited by 96 · see citing works
Zhang, S., Wang, J., & Pan, J. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1223218 · Cited by 93 · see citing works
Nanosystems in Cardiovascular Medicine: Advancements, Applications, and Future Perspectives
Omidian, H., Babanejad, N., & Cubeddu, L. X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071935 · Cited by 75 · see citing works
Recent advances in PLGA based nanocarriers for drug delivery system: a state of the art review
Pardeshi, S. R., Nikam, A. P., Chandak, P., Mandale, V., Naik, J., & Giram, P. S. (2021) · International Journal of Polymeric Materials · doi:10.1080/00914037.2021.1985495 · Cited by 74 · see citing works
Zhu, W., Wei, Z., Chang, H., & Weng, X. (2021) · Nanomaterials · doi:10.3390/nano11123346 · Cited by 71 · see citing works
Recent advances on nanoparticle-based therapies for cardiovascular diseases
Soumya, R. S., & Raghu, K. G. (2022) · Journal of Cardiology · doi:10.1016/j.jjcc.2022.02.009 · Cited by 68 · see citing works
Nanoparticle Based Treatment for Cardiovascular Diseases
Gupta, P., Garcia, E., Sarkar, A., Kapoor, S., Rafiq, K., Chand, H. S., & Jayant, R. D. (2018) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x18666180508113253 · Cited by 62 · see citing works
Lee, P., Zan, B. S., Chen, L.-T., & Chung, T. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s174962 · Cited by 57 · see citing works
Mao, Y., Koga, J., Tokutome, M., Matoba, T., Ikeda, G., Nakano, K., & Egashira, K. (2017) · International Heart Journal · doi:10.1536/ihj.16-457 · Cited by 54 · see citing works
Self-citationYokoyama, R., Ii, M., Tabata, Y., Hoshiga, M., Ishizaka, N., & Asahi, M. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0244 · Cited by 51 · see citing works
Nanomedicines in the treatment of colon cancer: a focus on metallodrugs
Farinha, P. F., Pinho, J. O., Matias, M., & Gaspar, M. M. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00916-7 · Cited by 45 · see citing works
Anti-inflammatory Nanoparticle for Prevention of Atherosclerotic Vascular Diseases
Koga, J., Matoba, T., & Egashira, K. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.35113 · Cited by 40 · see citing works
Self-citationShariati, L., Esmaeili, Y., Rahimmanesh, I., Babolmorad, S., Ziaei, G., Hasan, A., Boshtam, M., & Makvandi, P. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116933 · Cited by 39 · see citing works
Akagi, S., Nakamura, K., Miura, D., Saito, Y., Matsubara, H., Ogawa, A., Matoba, T., Egashira, K., & Ito, H. (2015) · International Heart Journal · doi:10.1536/ihj.14-338 · Cited by 38 · see citing works
Self-citationAkagi, S., Nakamura, K., Matsubara, H., Kondo, M., Miura, D., Matoba, T., Egashira, K., & Ito, H. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000352 · Cited by 36 · see citing works
Self-citationNeuroprotective potential of cerium oxide nanoparticles for focal cerebral ischemic stroke
Zhou, D., Fang, T., Lu, L.-Q., & Yi, L. (2016) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-016-1612-9 · Cited by 35 · see citing works
Kamps, J. A. A. M. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i2.163 · Cited by 34 · see citing works
Maarman, G. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-63245-2_10 · Cited by 33 · see citing works
Current Nanomedicine for Targeted Vascular Disease Treatment: Trends and Perspectives
Choi, K.-A., Kim, J. H., Ryu, K., & Kaushik, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012397 · Cited by 31 · see citing works
Nakamura, K., Akagi, S., Ejiri, K., Yoshida, M., Miyoshi, T., Toh, N., Nakagawa, K., Takaya, Y., Matsubara, H., & Ito, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235885 · Cited by 30 · see citing works
Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension
Nakamura, K., Matsubara, H., Akagi, S., Sarashina, T., Ejiri, K., Kawakita, N., Yoshida, M., Miyoshi, T., Watanabe, A., Nishii, N., et al. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6050048 · Cited by 29 · see citing works
Prostacyclin Analogue–Loaded Nanoparticles Attenuate Myocardial Ischemia/Reperfusion Injury in Rats
Yajima, S., Miyagawa, S., Fukushima, S., Sakai, Y., Iseoka, H., Harada, A., Isohashi, K., Horitsugi, G., Mori, Y., Shiozaki, M., et al. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.12.006 · Cited by 28 · see citing works
The Potential for Nanotechnology to Improve Delivery of Therapy to the Acute Ischemic Heart
Evans, C. W., Iyer, K. S., & Hool, L. C. (2016) · Nanomedicine · doi:10.2217/nnm.16.7 · Cited by 23 · see citing works
Yu, T., Xu, Q., Chen, X., Deng, X., Chen, N., Kou, M. T., Huang, Y., Guo, J., Xiao, Z., & Wang, J. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.100957 · Cited by 21 · see citing works
Waleka-Bargiel, E., Maćkiewicz, M., Romański, J., Dybko, A., Stojek, Z. J., & Karbarz, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119188 · Cited by 21 · see citing works
Multifunctional PLGA nanosystems: enabling integrated diagnostic and therapeutic strategies
Li, Y., Tao, T., Xiong, Y., Guo, W., & Liang, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1670397 · Cited by 20 · see citing works
Ijaz, S., & Nadeem, S. (2018) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2018.08.122 · Cited by 20 · see citing works
Nanomaterials-Mediated Therapeutics and Diagnosis Strategies for Myocardial Infarction
Lv, Q., Ma, B., Li, W., Fu, G., Wang, X., & Xiao, Y. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.943009 · Cited by 19 · see citing works
Drug Delivery and Nanoformulations for the Cardiovascular System.
Geldenhuys, W. J., Khayat, M. T. A., Yun, J., & Nayeem, M. A. (2017) · PubMed · Cited by 16 · see citing works
Fan, W., Li, Y., Sun, Q., Tay, F. R., & Fan, B. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.110856 · Cited by 17 · see citing works
Eshun, D., Saraf, R. S., Bae, S., Jeganathan, J., Mahmood, F. U., Dilmen, S., Ke, Q., Lee, D., Kang, P. M., & Matyal, R. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00467.2016 · Cited by 15 · see citing works
Kanaya, T., Miyagawa, S., Kawamura, T., Sakai, Y., Masada, K., Nawa, N., Ishida, H., Narita, J., Toda, K., Kuratani, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86781-3 · Cited by 13 · see citing works
Peptide-Guided Nanoparticle Drug Delivery for Cardiomyocytes
Li, D., Taylor, A., Shi, H., Zhou, F. J., Li, P., Joshi, J., Zhu, W., & Wang, S. F. (2024) · Biology · doi:10.3390/biology13010047 · Cited by 12 · see citing works
Two-Phase Biofluid Flow Model for Magnetic Drug Targeting
Boutopoulos, I. D., Lampropoulos, D. S., Bourantas, G. C., Miller, K., & Loukopoulos, V. C. (2020) · Symmetry · doi:10.3390/sym12071083 · Cited by 12 · see citing works
Levi, M., Epshtein, M., Castor, T., Gawaz, M., & Korin, N. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102274 · Cited by 12 · see citing works
Mechanoresponsive Drug Delivery Systems for Vascular Diseases
Navarro, J. F., & Lomora, M. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202200466 · Cited by 11 · see citing works
LipTube: Liposome Formation in the Tube Process Using Supercritical CO 2
Murakami, Y., Inoue, K., Akiyama, R., Orita, Y., & Shimoyama, Y. (2022) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.2c02095 · Cited by 11 · see citing works
Silica-Based Advanced Nanoparticles For Treating Ischemic Disease
Kudaibergen, D., Park, H. S., Park, J., Im, G., Lee, J., Joung, Y. K., Bhang, S. H., & Kim, J. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-022-00510-z · Cited by 10 · see citing works
Cardiac regenerative medicine: At the crossroad of microRNA function and biotechnology
Raso, A., & Dirkx, E. (2017) · Non-coding RNA Research · doi:10.1016/j.ncrna.2017.03.001 · Cited by 9 · see citing works
Sun, Y., Chen, L., Zhao, S., Shi, L., Li, H., Tian, W., & Qi, G. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8632 · Cited by 8 · see citing works
Fan, W., Li, Y., Liu, D., Sun, Q., Duan, M., & Fan, B. (2019) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-018-6216-4 · Cited by 8 · see citing works
Junqueira, L. A., Polonini, H. C., Loures, S., Raposo, N. R. B., Ferreira, A. O., & Brandão, M. A. F. (2018) · Current Drug Delivery · doi:10.2174/1567201815666181024141849 · Cited by 6 · see citing works
Modern Approaches To Cardiovascular Amyloidosis Treatment
Morozkina, S. N., Снетков, П. П., Olekhnovich, R. O., & Uspenskaya, M. V. (2021) · Russian Open Medical Journal · doi:10.15275/rusomj.2021.0416 · Cited by 4 · see citing works
Yajima, S., Lee, S. H., Yang, J., Vergel, M. D., Manna, M. K., Kusadokoro, S., Zhu, Y., Elde, S., Mullis, D. M., Venkatesh, A., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123167 · Cited by 3 · see citing works
PLGA nanoparticles for treatment of cardiovascular diseases
Ferreira, J. N. D. S., Vasconcelos, V. V. V., Figueiredo, B. S., Alves, D. P., de Abreu, A. L. L. V., de Souza, P. P., Costa, D. L. N., & da Silva, A. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91215-0.00015-7 · Cited by 3 · see citing works
Therapeutic Use of an Inhaled Drug Delivery in Pulmonary Hypertension: A Review
Kumbhare, U., Yelne, P., & Tekale, S. (2022) · Cureus · doi:10.7759/cureus.30134 · Cited by 3 · see citing works
Dong, J., Sun, M., Li, Y., & Xie, Z. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1788897 · Cited by 2 · see citing works
Drug-Functionalized Nanoparticles for Clinical Applications
Akgun, E., Barbieri, M. B., Silva, J. M., Shibu, A., Backx, B. P., Yeşilay, G., Hazeem, L. J., Vijaya, J. J., & Bououdina, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-63961-6_16 · Cited by 2 · see citing works
Nanotechnology-Based Therapeutics in ROS-Induced Cancer
Berehu, H. M., Anupriya, S., & Patnaik, S. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_254-1 · Cited by 1 · see citing works
Targeted drug delivery in cardiovascular therapy: Advancements in nanoparticle‐based systems
khafaji, A. T. A., Barakat, A. M., Zaidy, A. J. A., Khafaji, A. A. A., & Aouadi, R. F. A. A. (2026) · Polymer International · doi:10.1002/pi.70111 · Cited by 1 · see citing works
Sharma, N., Wani, S. N., Singh, S., Zahoor, I., Behl, T., & Malik, I. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13587-3.00009-6 · Cited by 1 · see citing works
Kong, L., Jia, Y., Li, T., Chen, Y., Pan, L., & Jia, C. (2021) · Science of Advanced Materials · doi:10.1166/sam.2021.4142 · Cited by 1 · see citing works
Nanotechnology-Based Therapeutics in ROS-Induced Cancer
Berehu, H. M., Anupriya, S., & Patnaik, S. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_254 · Cited by 1 · see citing works
Egashira, K. (2014) · Drug Delivery System · doi:10.2745/dds.29.333
Self-citationFuture directions in the treatment of coronary artery disease
Matoba, T., & Egashira, K. (2016) · Journal of the Japanese Coronary Association · doi:10.7793/jcoron.22.006
Self-citationNanoparticle-Mediated Drug Delivery System for Coronary Artery Disease
Matoba, T., Koga, J., Nakano, K., & Egashira, K. (2015) · Drug Delivery System · doi:10.2745/dds.30.299
Self-citationNanoparticle-Based Drug Delivery Systems for Cardiovascular Applications
Patel, A., & Pathak, Y. V. (2017) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-2092-4.ch014
Application and limitation of nanomedicine in different cardiovascular disease
Sharma, N. (2018) · International Journal of Pharma and Bio Sciences · doi:10.22376/ijpbs.2018.9.3.p52-60
Nano-liposome mediated delivery of the anti-diabetic protein E4orf1
Feizy, Z. (2018) · ThinkTech (Texas Tech University)
Cardiac Stem Cells to Cure Heart Through Nanotechnology
Kumar, P. K. R. (2020) · Journal of Regenerative Biology and Medicine · doi:10.37191/mapsci-2582-385x-2(3)-032
Atkinson, S. P. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0270
Nanoparticle-Based Drug Delivery Systems for Cardiovascular Applications
Patel, A., & Pathak, Y. V. (2019) · IGI Global eBooks · doi:10.4018/978-1-5225-8185-7.ch023
Nanotechnology-Based Therapeutics in ROS-Induced Cancer
Berehu, H. M., Anupriya, S., & Patnaik, S. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_254-2
Potensi Kuersetin Terenkapsulasi PLGA sebagai Terapi dalam Penatalaksanaan Kanker Payudara
Putra, P. R. S., Prasetyo, A. V., & Wahyuni, P. S. E. (2022) · Essential Essence of Scientific Medical Journal · doi:10.24843/estl.2022.v20.i01.p03
Application of the nano drug delivery system in the treatment of cardiovascular diseases
Velmurugan, R., & Swabanu, S. (2022) · Characterization and Application of Nanomaterials · doi:10.24294/can.v5i2.1683
Sharma, K., Paudel, K. R., Panth, N., Jha, S. K., & Devkota, H. P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99988-5.00004-8
Advances in Anti-inflammatory Therapies for Cardiovascular Disease and Atherosclerosis
Noman, A. A., Sejuti, S. R., Anuva, N. J., Nabin, M. N. R., Noman, M. J. I., Islam, M. H., Rahman, A., Tanme, T. A., Afrose, F., Hosen, M. N., et al. (2025) · Current Signal Transduction Therapy · doi:10.2174/0115743624366056250407071501
Drug Delivery to the Cardiovascular System: Application and Future Prospects
Umar, P. K., Jyoti, J., Asha, A., & Jain, S. K. (2025) · Methods in pharmacology and toxicology · doi:10.1007/978-1-0716-4554-3_15
A., D. P., Prabakaran, K., & Kuppusamy, D. B. (2025) · Current Applied Science and Technology · doi:10.55003/cast.2025.262219
Role of Medicinal Plant-Derived Nanoparticles Against Chronic Diseases
Siddiqui, M. A., Saidurrahman, M., & Usmani, A. (2025) · Springer eBooks · doi:10.1007/978-3-032-03604-9_16
Nanomaterials in Cardiovascular Applications
Singh, S. R., Thokchom, B., Bhavi, S. M., Abbigeri, M. B., Kulkarni, S. R., Padti, A. C., & Yarajarla, R. B. (2026) · Advanced structured materials · doi:10.1007/978-981-92-1034-3_11
- Authors
- Matoba, T., & Egashira, K.
- Affiliations
- Kyushu University (JP)
- ORCID
- Matoba, Tetsuya
- Venue
- International Heart Journal
- Published
- 2014
- Volume
- 55
- Issue
- 4
- Pages
- 281-286
- ISSN
- 1349-2365 (ISSN-L)
- 1349-3299
- OpenAlex
- W2094658016
- Cited by
- 83
- References
- 54
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 11 · 2021: 9 · 2020: 8 · 2019: 8 · 2018: 5 · 2017: 10 · 2016: 9 · 2015: 3 · 2014: 1
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- International Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Pharmacology and Nanomedicine Research
- Keywords
- nanoparticle drug delivery, cardiovascular disease, atherosclerosis, myocardial ischemia-reperfusion injury, passive targeting, active targeting, vascular permeability, reticuloendothelial system, targeted drug delivery, nanomedicine
- MeSH terms
- Animals, Cardiovascular Agents, Cardiovascular Diseases, Equipment Design, Humans, Drug Delivery Systems, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review